The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021

Details

• Personal Author:
  Mbaeyi, Sarah ; Oliver, Sara E. ; Collins, Jennifer P. ; Godfrey, Monica ; Goswami, Neela D. ; Hadler, Stephen C. ; Jones, Jefferson ; Moline, Heidi ; Moulia, Danielle ; Reddy, Sujan ; Schmit, Kristine ; Wallace, Megan ; Chamberland, Mary ; Campos-Outcalt, Doug ; Morgan, Rebecca L. ; Bell, Beth P. ; Brooks, Oliver ; Kotton, Camille ; Talbot, H. Keipp ; Lee, Grace ; Daley, Matthew F. ; Dooling, Kathleen
• Corporate Authors:
  United States. Advisory Committee on Immunization Practices. ; CDC COVID-19 Response Team. ; Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. ; University of Arizona College of Medicine. ; McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. ; University of Washington. ; Watts Healthcare Corporation. ; Harvard Medical School. ; Vanderbilt University School of Medicine. ; Stanford University School of Medicine. ; Kaiser Permanente Colorado. Institute for Health Research.
• Description:
  What is already known about this topic? In the United States, three COVID-19 vaccines are approved or authorized for primary vaccination against COVID-19.
  
  What is added by this report? The Advisory Committee on Immunization Practices issued recommendations for an additional primary mRNA COVID-19 vaccine dose for immunocompromised persons and a COVID-19 vaccine booster dose in eligible groups.
  
  What are the implications for public health practice? Health care professionals play a critical role in COVID-19 vaccination efforts, including for primary, additional primary, and booster vaccination, particularly to protect patients who are at increased risk for severe illness and death.
  
  Suggested citation for this article: Mbaeyi S, Oliver SE, Collins JP, et al. The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021. MMWR Morb Mortal Wkly Rep. ePub: 29 October 2021.
  
  mm7044e2.htm?s_cid=mm7044e2_w
  
  mm7044e2-H.pdf
  
  
• Subjects:
  Advisory Committees Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Immunization, Secondary Vaccination
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Article
• Name as Subject:
  Pfizer-BioNTech COVID-19 vaccine ; COMIRNATY ; Johnson & Johnson’s Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine
• Place as Subject:
  United States
• Location:
  North America
• Pages in Document:
  8 pdf pages
• Volume:
  70
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR) Advisory Committee on Immunization Practices (ACIP)
• Main Document Checksum:
  urn:sha-512:40beeae1222c536dd36c43fa43061e192f410051b24013bcc06c47fe3eeabb4b557a5efd38d500220107e39d9bb621f6262da1377e311b7b56874774699bd7c3
• Download URL:
  https://stacks.cdc.gov/view/cdc/111114/cdc_111114_DS1.pdf
• File Type:
  [PDF - 374.00 KB ]